Electroconvulsive therapy (ECT), traditionally used for psychiatric disorders, is increasingly recognized for its efficacy in managing movement disorders, even without psychiatric comorbidities....
Angela C. Combs,
MN, ARNP, PMHNP-BC
Owner, Nurse Practitioner, Three Rivers Psychiatry, PLLC
Understanding Extrapyramidal System Dysfunction: Causes, Symptoms, and Advances in Treatment
The extrapyramidal system, a complex neural network that coordinates involuntary movements and postural adjustments, plays a vital role in maintaining...
Angela C. Combs,
MN, ARNP, PMHNP-BC
Owner, Nurse Practitioner, Three Rivers Psychiatry, PLLC
Deutetrabenazine Proven Effective and Safe for Long-Term Tardive Dyskinesia Management
Tardive dyskinesia (TD), often associated with dopamine receptor antagonist (DRA) use, affects individuals with psychotic or mood disorders. This study...
Jeremy Schreiber,
MSN, PMHNP-BC
Founder, CEO, and Psychiatric-Mental Health Nurse Practitioner Prescriber, Enlighten Health Care
VMAT1 and VMAT2 Key to Neurotransmitter Packing, Opening Avenues for Neurological Treatments
The vesicular monoamine transporters, VMAT1 and VMAT2, play crucial roles in packing neurotransmitters into synaptic vesicles, essential for neurotransmission and...
Angela C. Combs,
MN, ARNP, PMHNP-BC
Owner, Nurse Practitioner, Three Rivers Psychiatry, PLLC
Promising Therapies for Tardive Dyskinesia: Efficacy and Safety of Valbenazine and Deutetrabenazine
Tardive dyskinesia (TD) is a neurological disorder characterized by involuntary movements, often caused by dopamine receptor antagonists. Vesicular monoamine transporter...
Michael Asbach,
DMSc, PA-C, Psych-CAQ
Associate Director, Interventional Psychiatry, DENT Neurologic Institute
